Framework models of tumor dormancy from patient-derived observations

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Long latency periods between primary tumor treatment and metastatic recurrence are often cited as evidence for clinical tumor dormancy.
• However, re-evaluating disease progression and tumor growth rates challenges the prevalence of clinical dormancy.

Purpose of the Study:

• To critically examine the concept of clinical tumor dormancy.
• To differentiate between clinical and cellular dormancy.
• To propose a conceptual framework for studying dormancy in cancer research.

Main Methods:

• Review of existing literature on tumor dormancy, cancer recurrence, and tumor growth dynamics.
• Analysis of clinical observations and experimental data related to disseminated tumor cells.
• Synthesis of homeostatic mechanisms influencing cancer progression.

Main Results:

• Clinical dormancy may be non-existent or far more common than previously assumed.
• Cellular dormancy, a non-proliferative state of disseminated tumor cells, is highly prevalent.
• Angiogenic and immunological control mechanisms contribute significantly to the chronic nature of cancer.

Conclusions:

• The concept of clinical tumor dormancy requires re-evaluation.
• Cellular dormancy is a frequent phenomenon with implications for cancer chronicity.
• A refined conceptual framework is needed to guide future research on tumor dormancy.